Cormedix Inc (CRMD)
5.375
-0.46
(-7.96%)
USD |
NASDAQ |
Apr 15, 16:00
5.39
+0.02
(+0.28%)
After-Hours: 20:00
Cormedix Price to Book Value: 4.213 for April 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 12, 2024 | 4.578 |
| April 11, 2024 | 5.009 |
| April 10, 2024 | 4.139 |
| April 09, 2024 | 3.723 |
| April 08, 2024 | 3.731 |
| April 05, 2024 | 3.692 |
| April 04, 2024 | 3.496 |
| April 03, 2024 | 3.237 |
| April 02, 2024 | 3.198 |
| April 01, 2024 | 3.269 |
| March 28, 2024 | 3.324 |
| March 27, 2024 | 3.261 |
| March 26, 2024 | 3.222 |
| March 25, 2024 | 3.198 |
| March 22, 2024 | 3.073 |
| March 21, 2024 | 3.057 |
| March 20, 2024 | 2.979 |
| March 19, 2024 | 3.002 |
| March 18, 2024 | 2.979 |
| March 15, 2024 | 2.986 |
| March 14, 2024 | 3.276 |
| March 13, 2024 | 3.057 |
| March 12, 2024 | 2.681 |
| March 11, 2024 | 2.759 |
| March 08, 2024 | 2.885 |
| Date | Value |
|---|---|
| March 07, 2024 | 2.838 |
| March 06, 2024 | 2.812 |
| March 05, 2024 | 2.780 |
| March 04, 2024 | 2.765 |
| March 01, 2024 | 2.874 |
| February 29, 2024 | 2.773 |
| February 28, 2024 | 2.773 |
| February 27, 2024 | 2.765 |
| February 26, 2024 | 2.592 |
| February 23, 2024 | 2.569 |
| February 22, 2024 | 2.538 |
| February 21, 2024 | 2.546 |
| February 20, 2024 | 2.577 |
| February 16, 2024 | 2.592 |
| February 15, 2024 | 2.561 |
| February 14, 2024 | 2.506 |
| February 13, 2024 | 2.412 |
| February 12, 2024 | 2.577 |
| February 09, 2024 | 2.491 |
| February 08, 2024 | 2.365 |
| February 07, 2024 | 2.303 |
| February 06, 2024 | 2.318 |
| February 05, 2024 | 2.334 |
| February 02, 2024 | 2.428 |
| February 01, 2024 | 2.381 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.784
Minimum
Jun 16 2022
14.95
Maximum
Sep 18 2019
4.932
Average
3.851
Median
Price to Book Value Benchmarks
| BioXcel Therapeutics Inc | -- |
| Assertio Holdings Inc | 0.5591 |
| Verastem Inc | 4.867 |
| Ocular Therapeutix Inc | 12.75 |
| PAVmed Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 4180.21 |
| Price | 5.375 |
| Earnings Yield | -17.12% |
| Market Cap | 295.52M |